127 related articles for article (PubMed ID: 24854406)
21. Editorial: targeted therapy for glioblastoma multiforme.
Halatsch ME
Anticancer Agents Med Chem; 2011 Oct; 11(8):692. PubMed ID: 21864239
[No Abstract] [Full Text] [Related]
22. Cancer: Resolving the stem-cell debate.
Gilbertson RJ; Graham TA
Nature; 2012 Aug; 488(7412):462-3. PubMed ID: 22919708
[No Abstract] [Full Text] [Related]
23. The glioblastoma vasculature as a target for cancer therapy.
Dimberg A
Biochem Soc Trans; 2014 Dec; 42(6):1647-52. PubMed ID: 25399584
[TBL] [Abstract][Full Text] [Related]
24. The interference of Notch1 target Hes1 affects cell growth, differentiation and invasiveness of glioblastoma stem cells through modulation of multiple oncogenic targets.
Cenciarelli C; Marei HE; Zonfrillo M; Casalbore P; Felsani A; Giannetti S; Trevisi G; Althani A; Mangiola A
Oncotarget; 2017 Mar; 8(11):17873-17886. PubMed ID: 28157712
[TBL] [Abstract][Full Text] [Related]
25. Emerging therapeutic targets and agents for glioblastoma therapy - part I.
Lo HW
Anticancer Agents Med Chem; 2010 Jul; 10(6):437. PubMed ID: 20937018
[No Abstract] [Full Text] [Related]
26. Proneural-mesenchymal transformation of glioma stem cells: do therapies cause evolution of target in glioblastoma?
Nakano I
Future Oncol; 2014; 10(9):1527-30. PubMed ID: 25145421
[No Abstract] [Full Text] [Related]
27. Rapid identification and validation of novel targeted approaches for Glioblastoma: A combined ex vivo-in vivo pharmaco-omic model.
Daher A; de Groot J
Exp Neurol; 2018 Jan; 299(Pt B):281-288. PubMed ID: 28923369
[TBL] [Abstract][Full Text] [Related]
28. SnapShot: glioblastoma multiforme.
Kotliarova S; Fine HA
Cancer Cell; 2012 May; 21(5):710-710.e1. PubMed ID: 22624719
[No Abstract] [Full Text] [Related]
29. Emerging therapeutic targets and agents for glioblastoma therapy--part II.
Lo HW
Anticancer Agents Med Chem; 2010 Sep; 10(7):511. PubMed ID: 21070189
[No Abstract] [Full Text] [Related]
30. Susceptibility-weighted imaging at ultra-high field (7 T) in the evaluation of brain tumors.
Zee CS; Yan C
World Neurosurg; 2012; 77(5-6):654-6. PubMed ID: 22381318
[No Abstract] [Full Text] [Related]
31. [MR imaging for accurate response monitoring in glioblastoma multiforme during bevacizumab therapy].
Korn A; Braun C; Fenchel M; Ernemann U; Horger M
Rofo; 2012 May; 184(5):397-401. PubMed ID: 22576602
[No Abstract] [Full Text] [Related]
32. Novel anti-glioblastoma agents and therapeutic combinations identified from a collection of FDA approved drugs.
Jiang P; Mukthavaram R; Chao Y; Bharati IS; Fogal V; Pastorino S; Cong X; Nomura N; Gallagher M; Abbasi T; Vali S; Pingle SC; Makale M; Kesari S
J Transl Med; 2014 Jan; 12():13. PubMed ID: 24433351
[TBL] [Abstract][Full Text] [Related]
33. ΔNp73/ETS2 complex drives glioblastoma pathogenesis- targeting downstream mediators by rebastinib prolongs survival in preclinical models of glioblastoma.
Cam M; Charan M; Welker AM; Dravid P; Studebaker AW; Leonard JR; Pierson CR; Nakano I; Beattie CE; Hwang EI; Kambhampati M; Nazarian J; Finlay JL; Cam H
Neuro Oncol; 2020 Mar; 22(3):345-356. PubMed ID: 31763674
[TBL] [Abstract][Full Text] [Related]
34. Bevacizumab rechallenge in glioblastoma patients with initial response to bevacizumab who later progress off therapy.
Balana C; Estival A; Pineda E
J Neurooncol; 2018 Sep; 139(3):779-780. PubMed ID: 29777419
[No Abstract] [Full Text] [Related]
35. Possible role for furazolidone in the treatment of glioblastoma multiforme.
Karamanakos PN
J BUON; 2013; 18(4):1097. PubMed ID: 24344045
[No Abstract] [Full Text] [Related]
36. Small molecules targeting histone demethylase genes (KDMs) inhibit growth of temozolomide-resistant glioblastoma cells.
Banelli B; Daga A; Forlani A; Allemanni G; Marubbi D; Pistillo MP; Profumo A; Romani M
Oncotarget; 2017 May; 8(21):34896-34910. PubMed ID: 28432280
[TBL] [Abstract][Full Text] [Related]
37. [Development of a novel targeted therapy for human glioblastoma].
Ishiuchi S
No Shinkei Geka; 2003 May; 31(5):495-500. PubMed ID: 12755022
[No Abstract] [Full Text] [Related]
38. Recurrent glioblastoma: not only surgery.
Xu T; Chen J; Lu Y
J Clin Oncol; 2011 Feb; 29(4):e102; author reply e103. PubMed ID: 21172889
[No Abstract] [Full Text] [Related]
39. Recombinant cytotoxins specific for cancer cells.
Debinski W
Ann N Y Acad Sci; 1999; 886():297-9. PubMed ID: 10667244
[No Abstract] [Full Text] [Related]
40. Alpha-secretase inhibition reduces human glioblastoma stem cell growth in vitro and in vivo by inhibiting Notch.
Floyd DH; Kefas B; Seleverstov O; Mykhaylyk O; Dominguez C; Comeau L; Plank C; Purow B
Neuro Oncol; 2012 Oct; 14(10):1215-26. PubMed ID: 22962413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
